Iteos Therapeutics Inc Cash Flow Quality Index
Iteos Therapeutics Inc cash flow quality index. Iteos Therapeutics Inc (ITOS) has a Cash Flow Quality Index of -1.33x as of December 2022. Operating cash flow of $-27.17 Million is below net income of $20.45 Million, suggesting accrual-heavy earnings not yet converted to cash. See ITOS financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Iteos Therapeutics Inc (2021–2022)
Cash flow quality index of Iteos Therapeutics Inc from 2021 to 2022. Historical Cash Flow Quality Index for Iteos Therapeutics Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore ITOS operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Iteos Therapeutics Inc Cash Flow Quality Index by Year (2021–2022)
Iteos Therapeutics Inc cash flow quality index by year from 2021 to 2022. Year-by-year earnings quality comparison for Iteos Therapeutics Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Iteos Therapeutics Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -1.15x | $-111.19 Million | $96.65 Million | ▼ -148.1% |
| 2021 | 2.39x | $513.14 Million | $214.52 Million | — |